Orbimed Advisors - PASSAGE BIO INC ownership

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q3 2023$6,661,971
-30.1%
10,124,5760.0%0.14%
-17.9%
Q2 2023$9,530,263
+11.4%
10,124,576
+13.4%
0.17%
+3.0%
Q1 2023$8,554,175
-30.6%
8,931,9990.0%0.17%
-28.8%
Q4 2022$12,326,159
+10.4%
8,931,9990.0%0.24%
+14.0%
Q3 2022$11,165,000
-47.0%
8,931,9990.0%0.21%
-45.8%
Q2 2022$21,080,000
-7.3%
8,931,999
+21.8%
0.38%
+3.5%
Q1 2022$22,729,000
-48.6%
7,331,999
+5.3%
0.37%
-35.0%
Q4 2021$44,214,000
-36.2%
6,962,8990.0%0.57%
-25.5%
Q3 2021$69,350,000
-24.8%
6,962,8990.0%0.76%
-18.2%
Q2 2021$92,189,000
-24.3%
6,962,8990.0%0.93%
-18.1%
Q1 2021$121,711,000
-31.6%
6,962,8990.0%1.14%
-27.0%
Q4 2020$178,041,000
+95.0%
6,962,8990.0%1.56%
+35.8%
Q3 2020$91,284,000
-52.0%
6,962,8990.0%1.15%
-57.2%
Q2 2020$190,296,000
+73.5%
6,962,8990.0%2.68%
+45.4%
Q1 2020$109,666,0006,962,8991.84%
Other shareholders
PASSAGE BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,497,922$1,648,6292.12%
Versant Venture Management, LLC 4,959,769$3,263,5281.74%
BML Capital Management, LLC 2,058,767$1,354,6691.24%
Acuitas Investments, LLC 418,161$275,1500.16%
Orbimed Advisors 10,124,576$6,661,9710.14%
Lynx1 Capital Management LP 190,124$125,1020.08%
Frazier Life Sciences Management, L.P. 1,758,219$1,156,9080.08%
TANG CAPITAL MANAGEMENT LLC 400,000$263,2000.04%
Marquette Asset Management, LLC 86,050$56,6210.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 506,600$333,3430.01%
View complete list of PASSAGE BIO INC shareholders